Di Li
- Molecular Biology top 10%
- Cancer Research top 10%
- Epidemiology
- Endocrinology, Diabetes and Metabolism top 10%
- Health, Toxicology and Mutagenesis top 5%
- Topics
- RNA modifications and cancer (10 papers)RNA Research and Splicing (8 papers)Retinoids in leukemia and cellular processes (4 papers)
- Journals
- Proceedings of the National Academy of SciencesCirculation ResearchThe Science of The Total Environment
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Di Li
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 123
- Molecular Biology 753
- Cancer Research 281
- Epidemiology 187
- Endocrinology, Diabetes and Metabolism 163
- Health, Toxicology and Mutagenesis 152
Countries citing papers authored by Di Li
This map shows the geographic impact of Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Li more than expected).
Fields of papers citing papers by Di Li
This network shows the impact of papers produced by Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Li. The network helps show where Di Li may publish in the future.
Co-authorship network of co-authors of Di Li
This figure shows the co-authorship network connecting the top 25 collaborators of Di Li. A scholar is included among the top collaborators of Di Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Li. Di Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | 8 | |
| 5 | 24 | |
| 6 | 4 | |
| 7 | 21 | |
| 8 | 19 | |
| 9 | 16 | |
| 10 | 15 | |
| 11 | 32 | |
| 12 | 13 | |
| 13 | 151 | |
| 14 | 79 | |
| 15 | 26 | |
| 16 | 15 | |
| 17 | 15 | |
| 18 | 41 | |
| 19 | 25 | |
| 20 | 30 |
About Di Li
Di Li is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Reproductive Medicine, having authored 62 papers that have together received 1.5k indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), RNA Research and Splicing (8 papers) and Retinoids in leukemia and cellular processes (4 papers). The work is most often cited by research in Cancer Research (281 citations), Biochemistry (84 citations) and Health, Toxicology and Mutagenesis (152 citations). Di Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Qiong Xu, Luhui Cai, Yiwen Zhang, Xiaofei Gu, Min Xia, Jiayi Song, Wenhua Ling, Hongshi Cai, Honghui Guo and Rong Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Circulation Research and The Science of The Total Environment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.